kentucky glp-1 gastrointestinal obstruction class action Glucagon-Like Peptide-1 Receptor Agonists and Adverse Events: A Systematic Review and Meta-Analysis Pharmaceutical giant Novo Nordisk is
Description
For now, the tension between innovation and compliance remains a defining feature of the GLP-1 landscape
M-Factor Goddess
Eli Lilly became the first healthcare or pharma company to reach a $1 trillion valuation
Comfort Support: The specialized probiotic Akkermansia muciniphila may help maintain healthy gut flora
All of these unanswered questions only add to the urgency of determining who is most likely to benefit from GLP-1s. : Luliia Burmistrova / Getty
THIS YEAR, at the American College of Rheumatology (ACR) Convergence 2025, a dedicated session explored whether glucagon-like peptide-1...
